D-Index & Metrics Best Publications

D-Index & Metrics

Discipline name D-index D-index (Discipline H-index) only includes papers and citation values for an examined discipline in contrast to General H-index which accounts for publications across all disciplines. Citations Publications World Ranking National Ranking
Microbiology D-index 90 Citations 23,228 263 World Ranking 171 National Ranking 1
Medicine D-index 86 Citations 23,032 273 World Ranking 7126 National Ranking 211

Overview

What is he best known for?

The fields of study he is best known for:

  • Internal medicine
  • Cancer
  • Surgery

Russell E. Lewis mainly focuses on Microbiology, Internal medicine, Mycosis, Aspergillosis and Caspofungin. His work in Microbiology tackles topics such as Virulence which are related to areas like Drosophila melanogaster and Melanogaster. His Internal medicine study combines topics from a wide range of disciplines, such as Voriconazole and Surgery.

His research investigates the connection between Mycosis and topics such as Zygomycosis that intersect with problems in Odds ratio. His Aspergillosis research is multidisciplinary, relying on both Amphotericin B and Posaconazole. His research in Caspofungin intersects with topics in Biological activity, In vitro, Pharmacology and Calcineurin.

His most cited work include:

  • Zygomycosis in a Tertiary-Care Cancer Center in the Era of Aspergillus-Active Antifungal Therapy: A Case-Control Observational Study of 27 Recent Cases (550 citations)
  • Zygomycosis in a Tertiary-Care Cancer Center in the Era of Aspergillus-Active Antifungal Therapy: A Case-Control Observational Study of 27 Recent Cases (550 citations)
  • Diagnosis and management of Aspergillus diseases: executive summary of the 2017 ESCMID-ECMM-ERS guideline (417 citations)

What are the main themes of his work throughout his whole career to date?

His scientific interests lie mostly in Microbiology, Internal medicine, Aspergillosis, Amphotericin B and Immunology. In his research, Mutant and Drosophila melanogaster is intimately related to Virulence, which falls under the overarching field of Microbiology. His Internal medicine research includes themes of Gastroenterology and Surgery.

His Aspergillosis research incorporates elements of Cancer, Mycosis, In vivo and Intensive care medicine. His Mycosis research integrates issues from Respiratory disease, Lung, Zygomycosis and Pathology. Russell E. Lewis works mostly in the field of Amphotericin B, limiting it down to topics relating to Pharmacology and, in certain cases, Caspofungin, as a part of the same area of interest.

He most often published in these fields:

  • Microbiology (59.50%)
  • Internal medicine (31.40%)
  • Aspergillosis (39.39%)

What were the highlights of his more recent work (between 2016-2021)?

  • Internal medicine (31.40%)
  • Microbiology (59.50%)
  • Intensive care medicine (18.18%)

In recent papers he was focusing on the following fields of study:

His primary areas of study are Internal medicine, Microbiology, Intensive care medicine, Voriconazole and Disease. While the research belongs to areas of Internal medicine, Russell E. Lewis spends his time largely on the problem of Gastroenterology, intersecting his research to questions surrounding Pharmacodynamics, Continuous infusion and Beta lactam antibiotics. His Microbiology study combines topics in areas such as Bacterial protein, Immune system and Virulence.

He interconnects Pharmacokinetics, Hematopoietic stem cell transplantation, Epidemiology, MEDLINE and Retrospective cohort study in the investigation of issues within Intensive care medicine. His Voriconazole study integrates concerns from other disciplines, such as Hematology, Echinocandin, Aspergillosis and Intensive care unit. His studies in Aspergillosis integrate themes in fields like Aspergillus fumigatus, Mucorales and Immunosuppression.

Between 2016 and 2021, his most popular works were:

  • Diagnosis and management of Aspergillus diseases: executive summary of the 2017 ESCMID-ECMM-ERS guideline (417 citations)
  • Global guideline for the diagnosis and management of mucormycosis: an initiative of the European Confederation of Medical Mycology in cooperation with the Mycoses Study Group Education and Research Consortium. (121 citations)
  • In vivo evolution of resistant subpopulations of KPC-producing Klebsiella pneumoniae during ceftazidime/avibactam treatment (67 citations)

In his most recent research, the most cited papers focused on:

  • Internal medicine
  • Cancer
  • Bacteria

Russell E. Lewis mainly investigates Internal medicine, Intensive care medicine, Voriconazole, Aspergillosis and Posaconazole. His Internal medicine research is multidisciplinary, incorporating elements of Gastroenterology, Surgery and Colistin. His Intensive care medicine study combines topics from a wide range of disciplines, such as Pharmacokinetics, Pharmacodynamics, Epidemiology, Disease and Acute kidney injury.

The Aspergillosis study combines topics in areas such as Aspergillus fumigatus and Surveillance study. The concepts of his Posaconazole study are interwoven with issues in Azole, Disease management, Aspergillus and Transplantation. His work in Aspergillus addresses issues such as Aspergillus terreus, which are connected to fields such as Amphotericin B.

This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.

Best Publications

Zygomycosis in a Tertiary-Care Cancer Center in the Era of Aspergillus-Active Antifungal Therapy: A Case-Control Observational Study of 27 Recent Cases

Dimitrios P Kontoyiannis;Michail S. Lionakis;Russell E. Lewis;Russell E. Lewis;Georgios Chamilos.
The Journal of Infectious Diseases (2005)

679 Citations

Invasive fungal infections in patients with hematologic malignancies in a tertiary care cancer center: an autopsy study over a 15-year period (1989-2003).

Georgios Chamilos;Mario Luna;Russell E. Lewis;Russell E. Lewis;Gerald P. Bodey.
Haematologica (2006)

615 Citations

Diagnosis and management of Aspergillus diseases: executive summary of the 2017 ESCMID-ECMM-ERS guideline

A. J. Ullmann;J. M. Aguado;S. Arikan-Akdagli;D. W. Denning.
Clinical Microbiology and Infection (2018)

563 Citations

Delaying Amphotericin B–Based Frontline Therapy Significantly Increases Mortality among Patients with Hematologic Malignancy Who Have Zygomycosis

Georgios Chamilos;Russell E. Lewis;Russell E. Lewis;Dimitrios P. Kontoyiannis.
Clinical Infectious Diseases (2008)

555 Citations

Antifungal drug resistance of pathogenic fungi

Dimitrios P Kontoyiannis;Russell E Lewis.
The Lancet (2002)

540 Citations

Combination of voriconazole and caspofungin as primary therapy for invasive aspergillosis in solid organ transplant recipients: A prospective, multicenter, observational study

Nina Singh;Nina Singh;Ajit P. Limaye;Graeme Forrest;Nasia Safdar.
Transplantation (2006)

398 Citations

Efficacy and toxicity of caspofungin in combination with liposomal amphotericin B as primary or salvage treatment of invasive aspergillosis in patients with hematologic malignancies

Dimitrios P Kontoyiannis;Ray Y Hachem;Russell E. Lewis;Gustavo A. Rivero.
Cancer (2003)

388 Citations

Pharmacology of Systemic Antifungal Agents

Elizabeth S. Dodds Ashley;Elizabeth S. Dodds Ashley;Russell Lewis;Russell Lewis;James S. Lewis;James S. Lewis;Craig Martin.
Clinical Infectious Diseases (2006)

356 Citations

Current Concepts in Antifungal Pharmacology

Russell E. Lewis.
Mayo Clinic Proceedings (2011)

347 Citations

Predictors of pulmonary zygomycosis versus invasive pulmonary aspergillosis in patients with cancer.

Georgios Chamilos;Edith M. Marom;Russell E. Lewis;Michail S. Lionakis.
Clinical Infectious Diseases (2005)

326 Citations

If you think any of the details on this page are incorrect, let us know.

Contact us

Best Scientists Citing Russell E. Lewis

Dimitrios P. Kontoyiannis

Dimitrios P. Kontoyiannis

The University of Texas MD Anderson Cancer Center

Publications: 187

Thomas J. Walsh

Thomas J. Walsh

Weill Cornell Medicine

Publications: 156

Oliver A. Cornely

Oliver A. Cornely

University of Cologne

Publications: 106

Olivier Lortholary

Olivier Lortholary

Université Paris Cité

Publications: 96

Emmanuel Roilides

Emmanuel Roilides

Aristotle University of Thessaloniki

Publications: 95

Paul E. Verweij

Paul E. Verweij

Radboud University Nijmegen

Publications: 84

John R. Perfect

John R. Perfect

Duke University

Publications: 74

David R. Andes

David R. Andes

University of Wisconsin–Madison

Publications: 74

Nathan P. Wiederhold

Nathan P. Wiederhold

The University of Texas Health Science Center at San Antonio

Publications: 73

Maiken Cavling Arendrup

Maiken Cavling Arendrup

Statens Serum Institut

Publications: 73

Sharon C.-A. Chen

Sharon C.-A. Chen

University of Sydney

Publications: 72

Matteo Bassetti

Matteo Bassetti

University of Genoa

Publications: 71

Monica A. Slavin

Monica A. Slavin

Peter MacCallum Cancer Centre

Publications: 70

Eric Dannaoui

Eric Dannaoui

Université Paris Cité

Publications: 67

Jacques F. Meis

Jacques F. Meis

Canisius-Wilhelmina Ziekenhuis

Publications: 65

Livio Pagano

Livio Pagano

Catholic University of the Sacred Heart

Publications: 63

Something went wrong. Please try again later.